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ABSTRACT

Recent studies have demonstrated that embryonic stem cells (ESCs) are
deficient in expressing type I interferons (IFN), the cytokines that play key roles in
antiviral responses. However, the underlying molecular mechanisms and biological
implications of this finding are poorly understood. In this study, I used a synthetic
RNA-based assay that can simultaneously assess multiple forms of antiviral responses
in ESCs. Dicer is an enzyme essential for RNA interference (RNAi), which is used as
a major antiviral mechanism in invertebrates but not clear in vertebrates. RNAi
activity is detected in wild-type ESCs but is abolished in Dicer knockout ESCs
(D−/−ESCs) as expected. D-/-ESCs have two unique phenotypes that distinguish it
from wild-type ESCs: slow proliferation rate and the inability to exit the pluripotent
state. Surprisingly, D−/−ESCs have gained the ability to express IFN, which is
otherwise deficient in wild-type ESCs. Furthermore, D−/−ESCs have constitutively
active double-stranded RNA (dsRNA)-activated protein kinase (PKR), an enzyme that
is also involved in antiviral response. D−/−ESCs show increased sensitivity to the
cytotoxicity resulting from synthetic RNA transfection that mimics virus infection.
The effects of synthetic dsRNA can be partly replicated with a synthetic B2RNA
corresponding to the retrotransposon B2 short interspersed nuclear element. B2RNA
has secondary structure features of dsRNA and accumulates in D−/−ESCs, suggesting
that B2RNA could be a cellular RNA that activates PKR and contributes to the
decreased cell proliferation and viability of D−/−ESCs. Treatment of D−/−ESCs with
a PKR inhibitor and IFNβ-neutralizing antibodies increased cell proliferation rate and
cell viability. Based on these findings, we propose that, in ESCs, Dicer acts as a
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repressor of antiviral responses and plays a key role in the maintenance of
proliferation, viability, and pluripotency of ESCs.
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CHAPTER I – INTRODUCTION

1.1

Overview of embryonic stem cells
Embryonic stem cells (ESCs) are pluripotent cells isolated from the blastocyst

stage of mammalian embryo (Thomson et al., 1998). ESCs have two unique
properties, namely self-renewal and pluripotency which distinguish it from other cell
types. Self-renewal refers to the ability of these cells to remain in undifferentiated
state during every round of cell division. Under suitable conditions, these cells can
differentiate into almost all cell types of the three germ layers when cultured in vitro
(Keller, 1995). Figure 1.1 schematically depicts development of ESCs after
fertilization of egg and sperm cells and their differentiation into somatic cells.
A fully developed adult mammals also consist of stem cells called adult stem
cells in different tissues of their body such as bone marrow, adipose tissue etc.
However, unlike ESCs these cells have limited self-renewal and can only differentiate
into certain cell lineages (Clarke & Frisen, 2001). For instance, adult stem cells
derived from bone marrow can only differentiate into very few somatic cell types
such as osteoblasts, chondrocytes, and adipocytes. It is also difficult to isolate and
process these cells in pure and adequate amount using current differentiation
protocols. Moreover, it can be cultured for only 10-15 passages in vitro in contrast to
ESCs which can be cultured almost indefinitely. Hence ESCs are a promising source
of cells for cell therapy and regenerative medicine (Evans & Kaufman, 1981; Guo et
al., 2015). Although ESCs were for the first time isolated from mouse blastocyst in
1981 (Evans & Kaufman, 1981), the prospect of using ESCs in regenerative medicine
became promising when ESCs were isolated from human embryos (Thomson et al.,
1998).
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The permissibility to use these ESCs for research has dual viewpoints owing
to both ethical and social concerns. Although ESCs are isolated from pre-implantation
embryos from ICM after separating it from trophoblasts stem cells and extraembryonic endoderm that collectively form fetus, ESCs themselves cannot form the
whole fetus and hence do not fall under the category of an ‘individual’ organisms.
Others, however, argue that these cells when implanted into an embryo, could form
chimeric individual and hence research involving these cells should be restricted
(Wert & Mummery, 2003). The generation of induced pluripotent stem cells from
reprogramming of somatic cells provided an alternative to producing ESC like cells
without requiring any embryos (Takahashi & Yamanaka, 2006) and has addressed the
ethical issues relating to ESC research. However, there are still concerns regarding the
use of ESCs in gene editing or individual cloning.
Research in ESCs have been focused in differentiating these cells into various
somatic cell types with the intent of using these cells for therapeutic implications.
Since these cells need to be transplanted inside body for therapeutics, the status of the
immune reactions associated with the transplantation should be studied. Moreover, the
ability of these cells to protect against various pathogenic infection should also be
assessed. Studies from our lab have demonstrated that ESCs have underdeveloped
innate immunity. Innate immunity can be developed during in vitro differentiation
into fibroblasts, but not to the level of naturally differentiated fibroblast cells
(D’Angelo et al., 2016b, 2017). These findings brought about important questions not
only important for the use of ESCs in regenerative medicine, but also for
understanding the development of innate immunity in developmental biology. Since
the differentiated cells derived from ESCs when transplanted creates wound, it can
elicit various inflammatory reactions. Moreover, it also needs to protect and respond
6

to various pathogenic infection. Hence, although these cells may have been
differentiated to the specific cell types to undergo different functions, the innate
immunity development should also be considered for their use in therapeutics (Guo et
al., 2015).

Figure 1.1 Schematic representation of formation of ESCs and differentiation
into somatic cells. ESCs are formed from fertilization of egg and sperm cells into zygote. The
zygotic cell undergoes rapid cell division to form blastocyst. ESCs are isolated from Inner Cell Mass
(ICM) of blastocyst. These ESCs can then be differentiated in vitro to almost any type of somatic cells.
An example shown here is differentiation of ESCs into fibroblasts.

1.2

Overview of innate immunity
Various microorganisms such as bacteria, viruses, and fungi possess the ability

to enter the body of vertebrates causing tissue damage and diseases. These
microorganisms are called pathogens and their pathogenicity largely depend upon
their ability to breach the defense mechanism or immunity of the body. Innate
immunity refers to non-specific and pre-existed defense mechanism against these
pathogens. They act within minutes or few hours after entry of pathogens and detect
specific molecular patterns in pathogens called pathogen associated molecular
patterns (PAMPs) through their cellular receptors called pattern recognition receptors
7

(PRRs), killing, and restricting the spread of these pathogens. These PAMPs are
molecular patterns specific to the pathogens and are not present in the host organism.
Somatic cells of our body consist of receptors located on both cell membrane and
cytosol that can recognize and bind to the PAMPs of pathogens. PRRs located on cell
membrane include Toll-like receptors (TLRs), whereas cytosolic PRRs include
Retinoic Acid-Inducible Gene I (RIG-I), Melanoma Differentiation Associated
protein 5 (MDA5), Double-stranded RNA-activated protein kinase (PKR), Nucleotide
binding Oligomerization Domain-like receptors (NLRs) etc. There are some
membrane-bound receptors such as TLR3 which are also present in the endosomes.
Activation of these receptors produce various cytokines and chemokines which attract
immune cells such as natural killer (NK) cells, dendritic cells, and macrophages
causing inflammation in the infected site. In the meantime, antigen presenting cells
such as dendritic cells migrate to secondary lymphoid organs to activate T cells and
initiate adaptive immunity (Akira et al., 2006; Murphy, 2008).
The ability of pathogens to cause diseases or pathogenicity depend upon its
ability to breach the innate immune system of our body. A pathogen needs to
overcome all these components of the innate immunity to successfully thrive and
cause diseases inside the body. It is the innate immunity that prevent initial
pathogenicity until adaptive immunity is activated (Murphy, 2008). Defects in any
components of the innate immune system could lead to deleterious infections by the
pathogens. For instance, zika virus infection in pregnant mice lacking type I IFN
signaling cause lethal fetal demise (Szaba et al., 2018).
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1.3

Antiviral innate immunity
Viruses are intracellular pathogens consisting of nucleic acids covered by

capsid proteins. Apart from some enveloped glycoproteins, viral nucleic acids are the
predominant PAMPs that are recognized by the host immune system to detect viral
infection. Viral genomes can be double stranded DNA (dsDNA), dsRNA, single
stranded RNA (ssRNA), or ssDNA unlike mammalian cells in which the genome is
exclusively dsDNA (Seth et al., 2006). Methylated CpG motifs in the host genome
and 5’ Guanine cap in the mRNA distinguishes the host nucleic acids from that of
viruses (Krieg, 2000; Shatkin & Manley, 2000). Of these viral PAMPs, dsRNA is the
most significant and common PAMP. DsRNA is usually produced during viral
infection cycle of most viruses including DNA viruses in the host cytoplasm. These
dsRNA can be bound to dsRNA binding receptors and activates mainly three types of
antiviral innate immunity: type I IFN signaling, RNA interference, or intrinsic
antiviral immunity depending upon species and cell type. Hence, to prevent the
activation of antiviral immunity by host derived dsRNA, it is sequestered in the
nucleus.

Antiviral type I IFN signaling
Antiviral type I IFN signaling is a protein based antiviral innate immunity
mechanism predominant in vertebrates (Napetschnig & Wu, 2013). Binding of virusderived dsRNA to the dsRNA binding receptors (PRRs) activate transcription factors
NFκB and IRF3 which then translocate to the nucleus and induce expression of type I
IFNs (Fig 1.2). These IFNs in turn activate hundreds of genes called interferons
stimulated genes (ISGs) which inhibit various stages of viral replication (Akira et al.,
2006; Platanias, 2005; Wu & Chen, 2014). In the meantime, IFNs acts in paracrine
9

manner to the neighboring cells to create antiviral state to prevent viral spread to other
areas.
There are three types of IFNs: type I, type II, and type III. Type I IFNs
(IFNα/β/ε/κ/τ/ω) are mostly produced as antiviral effectors during viral infection.
Type II IFNs only include IFNγ. It is restricted to immune cells like NK cells and Tlymphocytes and play important role in antigen presentation and activation of
macrophages (Ivashkiv & Donlin, 2014; Platanias, 2005; Schreiber, 2017; Wu &
Chen, 2014). Type III IFNs are structurally distinct from other types of IFNs but have
similar functions as that of type I IFNs. IFNs α and β are the most predominant type I
IFNs produced during viral infection. IFNβ is usually the first IFN to be produced by
tissue cells, such as fibroblasts which then elicits induction of IFNα by innate immune
cells (Taniguchi & Takaoka, 2002). The enhancer of IFNβ gene has binding sites for
different types of transcription factors: NFκB, IFN regulatory factor 3/7 (IRF3/7), and
ATF-2/c-Jun. Activation and binding of these transcription factors to the IFNβ
enhancer along with high mobility group protein A1 (HMGA1) forms a stable
enhancer complex leading to robust transcription of IFNβ and binding of only one of
these transcription factors cannot induce optimal transcription. Their cooperative
binding resulting in favorable conformational changes rather than protein-protein
interactions is responsible for effective transcription (Ford & Thanos, 2010). Of these
transcription factors, NFκB is considered the master transcription factor since it acts
as ‘molecular switch’ for antiviral IFN signaling. NFκB is a cytoplasmic protein
bound to a protein called inhibitor of NFκB (IκB) which retain it in the cytoplasm.
Activation of the viral PRRs lead to phosphorylation of Inhibitor of IκB kinase (IKK)
which ultimately phosphorylates IκB and exposed nuclear localization sequence of
NFκB allows translocation into the nucleus (Napetschnig & Wu, 2013). Similarly,
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viral infection and subsequent PRR activation also hyper-phosphorylate IRF3 leading
to nuclear translocation. IRF7 activation and translocation to the nucleus usually
occurs after translocation of IRF3 and its activation leads to robust production of
IFNs. ATF-2/c-Jun transcription factors are already present in the nucleus and binding
of these transcription factors elicits its binding to the enhanceosome of IFNβ (Ford &
Thanos, 2010; Hiscott, 2007).
IFNβ mediates its antiviral effect by binding to membrane receptors IFN α/β
receptors 1 and 2 (IFNAR1 and IFNAR2). This leads to dimerization of the receptors
thus attracting Janus Kinases (Tyk2 and Jak1). These kinases phosphorylate
transcription factors called signal transducers and activators of transcription 1 and 2
(STAT1 and STAT2). Heterodimerization of these transcription factors along with
IRF9, then translocate to the nucleus and lead to transcription of numerous IFNstimulated genes, such as PKR, ISG15, and Mx. There are about 300 of these ISGs
which induce antiviral responses such as apoptosis of the infected cells and inhibit
viral replication (Akira et al., 2006; Seth et al., 2006). In non-canonical pathway,
activation of this signaling also lead to homodimerization of STAT1 transcription
factors after phosphorylation which then translocate to the nucleus and bind to gamma
activated sequence (GAS) (Ivashkiv & Donlin, 2014). Consequently, proinflammatory genes such as IL-1, TNFα etc. are expressed attracting immune cells to
control viral infection. In addition to these IFNs, various pro-inflammatory cytokines
and chemokines are produced resulting in a condition called inflammation. This
confines the infection within the infected area and attract various immune cells to the
site of infection to effectively wipe out the infection (Mogensen & Paludan, 2001).
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Figure 1.2. Schematic representation of type I IFN signaling in vertebrate
somatic cells. These cells have dsRNA binding cytoplasmic receptors which recognize dsRNA
produced during viral infection as well as transfected synthetic dsRNA and activate transcription
factors NF-ĸB and IRF3. These transcription factors then translocate to the nucleus and initiate
transcription of type I IFNs such as IFNβ and other inflammatory cytokines. The IFNs then act in both
autocrine and paracrine manner to form transcription factor complex called IFN stimulated response
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element (ISRE) which then transcribes ISGs. These ISGs are antiviral proteins which act on various
stages of virus replication to prevent virus infection and spread. DsRNA binding receptors such as PKR
also induce apoptosis in the infected cells by phosphorylating eIF2α and halting both viral and cellular
mRNA translation.

Antiviral RNA interference
In plants and invertebrates, RNA interference (RNAi) is used as an alternative
antiviral mechanism since they are unable to produce IFNs (Agius et al., 2012; Nayak
et al., 2013). Like antiviral IFN system, viral dsRNA elicits antiviral RNAi system in
plants since most of these viruses infecting them produce dsRNA during their
replication cycle. The viral dsRNA is cleaved by an RNase III enzyme called Dicer
into short fragments of about 21-23 bps small interference RNA (siRNA). These
fragments are then loaded into a complex called RNA-induced silencing complex
(RISC). One of these fragments which act as guide strand bind to the viral RNA
leading to degradation of viral RNA. This antiviral system uses virus derived RNA
instead of proteins (IFNs) to inhibit viral replication and hence also known as RNAbased antiviral system (Song & Rossi, 2017). Figure 1.3 schematically depicts
antiviral RNAi pathway. The role of Dicer is also to generate miRNAs from
endogenous dsRNA structures called primary miRNAs. These miRNAs modulate the
translation of messenger RNAs by usually binding to their 3’-UTR regions
(Wienholds & Plasterk, 2005). In vertebrates, there is a single Dicer gene that encodes
the Dicer enzyme whose primary function is to generate miRNAs although there are
also reports suggesting that it can also cleave viral derived dsRNA (Li et al., 2013;
Maillard et al., 2013; Wienholds & Plasterk, 2005). However, in plants and
invertebrates, the Dicer functions to cleave viral derived dsRNA in addition to
13

generating miRNAs (Agius et al., 2012; Nayak et al., 2013). Hence there are different
isoforms of Dicer to specifically process these different dsRNA substrates. For
instance, in Drosophila, there are two isoforms of Dicer called Dicer1 and Dicer2 to
generate endogenous miRNA and virus-derived siRNA respectively (Nayak et al.,
2013). It can be inferred that RNAi based antiviral immunity which is prevalent in
invertebrates and plants was replaced by IFN based antiviral immunity in vertebrates
over course of evolution.

Figure 1.3. Schematic representation of antiviral RNAi innate immunity. DsRNA
produced during viral replication cycle is cleaved into 21-23 bps siRNAs by Dicer enzyme. These
siRNAs are then loaded into a complex called RNA-inducing silencing complex (RISC), siRNA gets
unwound and one of the strands then bind complementarily to viral RNA leading to its degradation and
ultimately inhibiting viral replication.
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Intrinsic Antiviral immunity
Host cells constitutively express various antiviral proteins which can inhibit
virus infection directly without inducing gene expression as in type I IFN system.
These pre-existed antiviral proteins usually render host cells non-permissive for virus
infections and are called intrinsic antiviral factors. Although the definition of intrinsic
antiviral immunity encompasses antiviral RNAi and more primitive CRISPR-CAS
based antiviral immunity in bacteria, this type of immunity in vertebrates refers to
pre-existed antiviral proteins in vertebrates where antiviral type I IFN system is
predominant. Since these host antiviral proteins are further upregulated by IFNs, these
proteins are also categorized as ISGs (Guo, 2017; Yan & Chen, 2012). PKR and
Oligoadenylate cyclase (OAS)/RNase L are two major intrinsic antiviral proteins
expressed at higher basal levels in most of the vertebrate cell types in uninfected state.
Both antiviral proteins are activated by viral dsRNA. Activation of PKR leads to
inhibition of both viral and cellular protein synthesis by phosphorylating eIF2α and
induces apoptosis in the infected cells preventing viral multiplication (Thomson,
2001). In OAS/RNase L system binding of dsRNA to OAS produce 2’-5’
oligoadenylates which act as secondary messengers, dimerizing and activating latent
RNase L. Activated RNase L then cleaves both viral and cellular RNA leading to
apoptosis of the infected cell (Barber, 2001). Various other intrinsic antiviral proteins
have also been discovered. For instance, cytidine deaminase family of protein called
APOBEC3G (Mbisa et al., 2007), tripartite motif family protein TRIM5α (Stremlau et
al., 2006), and Bone marrow stromal cell antigen 2 (BST2) protein (van Damme et al.,
2008) have intrinsic antiviral properties against HIV virus infection. Similarly, IFN
induced transmembrane proteins (IFITM) (Brass et al., 2009) and IFN induced protein
with tetratricopeptide repeats (IFIT) (Pichlmair et al., 2011) acts as intrinsic antiviral
15

proteins during Influenza virus infection. Hence, these constitutively expressed
antiviral proteins provide intrinsic antiviral innate immunity without gene expression
and acts directly to prevent viral infection.

1.4

Antiviral innate immunity in ESCs
Unlike differentiated somatic cells, type I IFN system in ESCs is

underdeveloped. Viral specific PRRs are either not expressed or are inactive in ESCs.
In mESC, hESCs, and hiPSCs, MDA5 and TLR3 are expressed at undetectable levels
(Chen et al., 2010; Wang et al., 2013). In mESCs, poly (IC) transfection or infection
with La Crosse virus, West Nile virus, or Sendai virus did not produce type I IFNs
(Wang et al., 2013). Similarly, in hESCs and hiPSCs, dsRNA did not produce type I
IFNs (Chen et al., 2010). However, in mESCs, type I IFNs could decrease viral
infectivity by activating STAT1 transcription factor and inducing ISGs although the
level of ISGs were very low compared to differentiated cells (Wang, et al., 2014b). In
contrast to mESCs, hESCs and hiPSCs did not have any response to type I IFNs.
Treatment of these cells with IFNβ could not produce ISGs although the basic
signaling proteins for this response was expressed in these cells which is due to higher
expression of suppressor of cytokine signaling protein (SOCS1). This protein inhibits
phosphorylation of STAT1 transcription factor by inhibiting Tyk2 and JAK1 activity
(Gruber et al., 2013). In ESCs, PKR is constitutively expressed at comparable levels
with that of differentiated somatic cells. However, the intrinsic antiviral contribution
of PKR is still not clear. In mESCs, although PKR is activated by poly (IC) and
during La Crosse virus infection, PKR activation do not correlate with viral infectivity
(Wang et al., 2013). In hESCs and hiPSCs, PKR could not be activated by dsRNA
16

(Chen et al., 2010). These studies have hence shown that type I IFN system is
defective in ESCs.
The underdeveloped type I IFN system gets developed with differentiation of
ESCs into differentiated cells suggesting it to be an intrinsic property of these cells.
When mESCs were differentiated into fibroblast-like cells using retinoic acid, these
differentiated cells did produce IFNs. The master transcription factor NFκB got
activated in response to poly (IC) as well as during Chikungunya and La Crosse virus
infections (D’Angelo et al., 2016). Similarly, hESCs when differentiated into
trophoblast cells activated IFN system (Chen et al., 2010). Since NFκB is the major
regulator of IFN system and we have not seen any reports from others and from our
own lab, it is more likely that activation of IFN system and pluripotency are inversely
correlated. Targeting NFκB degradation by siRNA led to decrease in the levels of
pluripotency factors Oct4 and nanog in hESCs (Takase et al., 2013). Similarly, ESCspecific miRNAs namely miR-291b and miR-293 leads to suppression of NFκB
activation in ESCs (Gruber et al., 2014). Type I IFN signaling when ectopically
activated in hESCs by activation of IRF7 transcription factor caused defects in
differentiation of these cells (Eggenberger et al., 2019). It seems that pluripotency,
and underdeveloped type I IFN system are finely balanced in ESCs by NFκB
transcription factor.
An obvious question would be how do these cells protect themselves from
viral infection? RNA interference (RNAi) has been put forth as an alternative antiviral
innate immunity in ESCs (Li et al., 2013; Maillard et al., 2013). Since dsRNA
produced during virus infection activates well developed IFN system in differentiated
cells and having complete machinery for RNAi and underdeveloped IFN system in
pluripotent ESCs, it is more likely that these two cell types utilize two different
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antiviral mechanisms (Pare & Sullivan, 2014). Viral derived siRNAs of about 22
nucleotides were detected when mESCs were infected with Encephalomyocarditis
virus or Nodamura virus with deleted B2 region (viral suppressor of RNAi). To
inactivate RNAi pathway, Dicer enzyme, which cleaves dsRNA to generate siRNA
was deleted in ESCs. These siRNAs were absent in Dicer knockout (D-/-) ESCs
suggesting the functionality of antiviral RNAi in ESCs (Maillard et al., 2013).
However, low percentage of viral derived siRNAs in virus infected ESCs question the
physiological significance of the role of RNAi in these cells (TenOever, 2017).
Moreover, somatic mammalian cells with inactivated type I IFN system could process
long dsRNA to trigger sequence specific gene silencing indicating the biochemical
functionality of RNAi in these cells. However, there was no difference in viral load
when RNAi was ablated in these IFN inactivated cells (Maillard et al., 2016). The role
of antiviral RNAi in mESCs is hence highly controversial (TenOever, 2017). It has
also been shown that ESCs consist of intrinsic repertoire of ISGs such as IFITM and
BST2 which protect themselves against various virus infections and these ISGs
repertoire are lost during differentiation into terminally differentiated cells (Wu et al.,
2018). Our lab also determined the activation of PKR, an ISG in mESCs during viral
infection (Wang et al., 2013). It may be possible that the unique intrinsic expression
of these ISGs protect ESCs against viral infections. Recently, endogenous reverse
transcriptase encoded by retrovirus like genes in mESCs has been shown to provide
antiviral immunity against Encephalomyocarditis virus by cleavage of viral RNADNA hybrid produced by this endogenous reverse transcriptase by RNase H enzyme
(Wu et al., 2021). Antiviral innate immunity in ESCs is hence more likely provided
by various non-canonical forms of antiviral mechanisms other than type I interferon
system.
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1.5

Role of Dicer in antiviral immunity and RNA biogenesis pathways
Dicer is a large (218 kDa in mouse) cytoplasmic ribonuclease III enzyme

which cleaves dsRNA structures into shorter fragments and modulate its effects by
complementary binding to its cognate RNA. DsRNA is derived either endogenously
as precursor miRNAs or dsRNA structures from non-coding RNAs or exogenously as
viral derived dsRNA during viral replication (Song & Rossi, 2017). There are five
distinct domains in Dicer: Helicase domain, domain of unknown function (DUF283),
Piwi/Argonaut/Zwille domain (PAZ), RNase IIIa and RNase IIIb domains, and
dsRNA binding domain (RBD). These domains form an ‘L” shape consisting of head,
body, and base. The head region contains the PAZ domain which binds to the
3’overhang region of dsRNA substrate. The body consist of RNase III domains, RBD,
and DUF. RNase III domains are the catalytic sites for Dicer and each of these
domains cut one of the bound dsRNA whereas the base consist of N-terminal helicase
domain. In most of invertebrates and plants, there are different isoforms of Dicer
enzyme specific for these two sources of dsRNA (Sinkkonen et al., 2010; Svobodova
et al., 2016). For instance, in Drosophila melanogaster, Dicer1 is specific for
producing mature miRNAs whereas Dicer2 cleaves viral derived dsRNA conferring
antiviral immunity. Vertebrates usually have only one Dicer isoform which resembles
with Dicer1 (Du et al., 2008; Sinha et al., 2018). However, Dicer isoform with
truncated N-terminal helicase domain has been found in mammalian oocytes (Flemr
et al., 2013), ESCs, neural stem cells, and NIH3T3 cells (Poirier et al., 2021). In
mammals, although Dicer predominantly function in the miRNA pathway, there have
also been reports of the role of Dicer in antiviral RNAi as well as in the regulation of
endogenous cellular RNA or transposons.
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Role of Dicer in miRNA biogenesis pathway
In mammalian cells, the canonical role of Dicer is to process miRNAs.
Primary miRNAs transcribed from RNA polymerase II are cleaved by nuclear
microprocessor called Drosha and DGCR8. The so produced precursor miRNAs with
stem-loop structures are then transported into cytoplasm through exportin 5. Dicer
then cleaves these precursor miRNAs into about 20-23 bps long mature miRNAs and
load them in a complex called RNA-induced silencing complex (RISC) containing
argonaute proteins. RISC with one of the strands called guide strand bind to the
mRNA usually at its 3’end inhibiting translation and mRNA degradation (Wienholds
& Plasterk, 2005). This process of modulating mRNA expression is called posttranscriptional gene silencing (PTGS) (Hammond et al., 2001). In addition to PTGS
as a mechanism of gene silencing, mammalian Dicer also modulates gene expression
through transcriptional gene silencing (TGS). Role of Dicer was evident in TGS by its
ability to inhibit the accumulation of long interspersed element-1 (LINE-1) (Bodak et
al., 2017), heterochromatin formation, and centromeric silencing (Kanellopoulou et
al., 2005). TGS is well-developed in plants, Drosophila, and Schizosaccharomyces
pombe. In TGS, siRNAs produced due to Dicer cleavage are complementary to the
promoter regions; binding of these siRNAs to argonaute protein (for instance, Ago-1
in S. pombe) guide the siRNA to bind to the promoter region and inhibits
transcription initiation through histone modification (H3K9me2 and H3K27me3)
(Matzke & Birchler, 2005). In plants, this TGS complex also induce promoter DNA
methylation at CpG sites adding further layer of transcription inhibition (Vaucheret &
Fagard, 2001).
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Role of Dicer in antiviral innate immunity
Since Dicer can bind to dsRNA structures and during virus infections, virusderived dsRNA is usually produced as a byproduct during their replication, Dicer can
promote degradation of viral RNA by processing these dsRNA structures through
antiviral RNAi (discussed in detail in 1.3 and 1.4). In addition, Dicer indirectly
modulates expression of genes involved in type I IFN signaling through miRNAs
(Sedger, 2013). There are also embryonic specific miRNAs such as miR-291b-5p and
miR-293 which target mRNA of RelA subunit of NF-ĸB (Luningschror et al., 2012).

Role of Dicer in regulation of endogenous dsRNA structures
DsRNA structures are also produced endogenously inside the mammalian
cells mostly by retrotransposons. These are the mobile genetic elements that use
endogenous reverse transcriptase so that they can integrate into the genome. Usually,
they are found in the heterochromatin silenced by various epigenetic mechanisms.
There are three types of retrotransposons: Long interspersed element-1 (LINE-1 or
L1), Long Terminal Repeat (LTR), and Short interspersed nuclear elements (SINE)
which includes Alu elements in humans and B1 and B2RNA in mouse genome.
During the process of retro-transposition, dsRNA structures are formed which are
cleaved by Dicer to prevent their deleterious effects (Slotkin & Martienssen, 2007).
B1RNA derived small RNAs were absent in Dicer deleted mESCs although B1RNA
precursor was comparable to wild type mESCs suggesting the role of Dicer in
cleaving these RNAs (Babiarz et al., 2008). Similarly, the RNA levels of LINE-1
were significantly increased in D-/-ESCs compared to that of wild-type mESCs
(Bodak et al., 2017). In human HEK293FT cells, deletion of Dicer led to
accumulation of dsRNA detected by J2 antibody specific to dsRNA structures more
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than 30bps (White et al., 2014). In an eye disease called Age-related Macular
Degeneration, inflammatory response was seen due to the increase in Alu elements
and loss of Dicer (Kaneko et al., 2011; Tarallo et al., 2012). Hence, Dicer prevents the
deleterious effects of these endogenously produced dsRNA structures by cleaving into
shorter fragments.

1.6

The role of PKR in antiviral immunity, cell cycle, and translational switch
Double stranded RNA-activated protein kinase (PKR) is an interferon

stimulated gene upregulated and activated during virus infection. PKR consist of two
double-stranded RNA binding domains (dsRBD) and a kinase domain joined together
by a linker. In its inactive state, the kinase domain is buried in the dsRBD so that it is
inactivated. Binding to appropriate substrate by dsRBD release the kinase domain and
homodimerization of two PKR molecules lead to phosphorylation specifically at
Thr446 and Thr451 of PKR leading to the activation of kinase domain of PKR.
(Raven & Koromilas, 2008; Williams, 1999). DsRNA is the major substrate bound by
dsRBD. DsRNA as short as 30bp can be bound to dsRBD and activate PKR.
Although, dsRNA less than 30bp such as mature miRNAs (about 21bp) cannot
activate PKR (Zheng & Bevilacqua, 2004), dsRNA structures produced inside the cell
during transcription of various transposon or retrotransposons such as B2RNA in
mouse or Alu elements in humans can also activate PKR (Kaneko et al., 2011).
However, dsRNA are not the only substrates that activate PKR. Various polyanionic
molecules such as heparin, dextran sulphate, chondroitin sulphate etc. also activates
PKR (Hovanessian et al., 1987). In response to various stress, PKR is also activated
by mouse cellular protein RAX (PACT in humans) (Bennett et al., 2004; Li et al.,
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2006). Activation of PKR inhibit initiation of protein synthesis and ultimately lead to
apoptosis by phosphorylating eIF2α. To initiate translation for polypeptide synthesis,
Met-tRNAi should be delivered to the 40S ribosome which is done by eIF2. This
activity is modulated by α subunit of eIF2. Phosphorylation of eIF2α at Ser51 residue
by activated PKR render the eIF2 unable to transfer Met-tRNAi to the translational
complex thereby inhibiting mRNA translation (García et al., 2006).

Role of PKR in antiviral innate immunity
PKR as an antiviral protein was discovered when IFN pretreated HeLa cells
infected with vaccinia virus caused translation inhibition of both viral and cellular
mRNAs (Metz & Esteban, 1972). Since then, various viral proteins inhibiting PKR
activity has been discovered such as E2 and NS5A of Hepatitis C virus, NS1 of
Influenza virus, Tat protein of HIV-I virus etc (Garcia et al., 2007). Similarly,
Chikungunya virus, a positive sense single stranded RNA virus of Togaviridae family
consist of ns4 protein as potent inhibitor of PKR activation (Rathore et al., 2013).
However, inhibitor of PKR has not been studied or found for La Crosse virus, a
negative sense single stranded RNA virus of Bunyaviridae family (Streitenfeld et al.,
2003). Usually, the amount of virus derived dsRNA produced during virus infection
cycle determines the degree of activation status of PKR, however, it is complicated by
the fact that different viruses have various PKR inhibitors strategies. In addition to it,
activated PKR also act on other signaling pathways such as NFκB, p53, caspase 8,
STAT1, IRF1 etc. causing diverse cellular effects (Nallagatla et al., 2011).
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Role of PKR in cell proliferation
PKR also has a regulatory role during cell division. Ectopic expression of
PKR in mammalian cells decrease its proliferation rate (Koromilas et al., 1992)
whereas catalytically inactive mutant of PKR when expressed in NIH3T3 cells and
the cells when injected in mice cause tumor formation (Barber et al., 1995). Similarly,
the catalytically inactive mutant of PKR when expressed in human glioblastoma cell
line cause distortion in cell cycle profile with increase in number of cells in G1 phase.
Moreover, PKR knockout MEF cells showed slower growth kinetics compared to
wild-type cells (Zamanian-Daryoush et al., 1999). PKR is activated by cellular
dsRNA such as inverted Alu repeats or BRNA during mitotic phase of cell cycle
where nuclear membrane gets disintegrated. The activated PKR acts as mitotic
regulator by inhibiting translation and condensing chromosomes (Kim et al., 2014;
Walters et al., 2009). Hence, in addition to antiviral function, PKR also function as a
cell cycle regulator.

Role of PKR as translational modulator in ESCs
In ESCs, there is a poor correlation between mRNA and protein levels (Munoz
et al., 2011). In fact, the rate of translational efficiency is significantly less in ESCs
when compared to that of embryoid bodies differentiated from these ESCs (Easley et
al., 2010). It has been found that eIF2α, a substrate of PKR regulates the translational
control in ESCs. The level of peIF2α is higher in ESCs than in differentiated cells and
these peIF2α selectively promotes translation of pluripotency factors such as nanog
and C-MYC through alternative open reading frames while inhibiting global
translation. The level of peIF2α is hence maintained at higher levels in ESCs by LIF
signaling pathway by inhibiting the expression of eIF2α phosphatase called
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constitutive repressor of eIF2α phosphatase (CReP) and BMP4 signaling pathway by
increasing the level of PKR phosphorylation (Friend et al., 2015). Interestingly,
increasing translational rate in ESCs push towards differentiation (Easley et al., 2010)
whereas decreasing translational rate decreases the differentiation potential of ESCs
(Bulut-Karslioglu et al., 2018) which suggests that maintaining the balance between
transcriptional and translational profile is necessary for ESCs. Hence, despite having
an open chromatin state and highly active transcription rate, ESCs selectively permits
expression of pluripotency genes and represses differentiation genes by selective
translational switch.
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CHAPTER II – OBJECTIVE AND SIGNIFICANCE

Embryonic stem cells hold promising potential in the field of cell therapy and
regenerative medicine due to their ability to differentiate into almost all somatic cell
types. As these cells are the early progenitor cells from which a whole organism is
developed, these cells are also important to study developmental processes. While the
focus in ESC research is more towards generating different types of somatic cells
primarily driven by primarily driven by their potential use in regenerative medicine,
an overlooked but significant area of research is on the basic research of stem cell
biology. For the past several years we are starting to witness the expansion of ESC
research not only to translational medicine but also to many areas of basic cell biology
that have resulted in many unexpected findings. An attenuated innate immune
response is one of such findings that has led to the hypothesis that mammals may
have adapted different antiviral mechanism at different stages of development (Guo,
2019; Guo et al., 2015). Challenging the conventional notion that innate immunity is
inherent and ‘innate’ regardless of the cell types based on their origin, developmental
status, and functionality, our lab and others have shown that innate immunity in ESCs
is underdeveloped. Both mouse and human ESCs do not produce type I IFNs in
response to virus and bacterial infections. Moreover, we have shown that mouse ESCs
are also unresponsive to various inflammatory cytokines such as IFNγ and TNFα.
While it may be beneficial not to have innate immune responses since these cells are
the progenitor cells for almost all somatic cells and these responses often cause
cytotoxic effect which can damage these progenitor cells, it can also be argued that
deficiency in innate immunity also leaves these cells vulnerable to pathogenic
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infections. It also raises to an interesting research question on the mechanism behind
the unique immunological properties of ESCs and the possible alternative innate
immunity pathways. This study focusses on the possible mechanism behind
underdeveloped antiviral innate immunity in mouse ESCs. We aim to determine the
potential role of an enzyme called Dicer, the primary enzyme in both miRNA and
antiviral RNA interference pathway, in modulation of antiviral responses in ESCs.
The other important property of ESCs is their rapid proliferation rate. Antiviral
responses in somatic cells cause decreased proliferation and D-/-ESCs also have
retarded proliferation rate. Our lab has shown that PKR is the only active antiviral
pathway in ESCs. Infection of these cells with La Crosse virus or transfection with
poly (IC), an analog of virus infection, decrease the proliferation rate of ESCs. We
aim to determine the correlation between reduced proliferation and activation of
antiviral responses in D-/-ESCs. Overall, our study is focused to study the role of
Dicer in the repression of antiviral innate immunity pathways to modulate type I IFN
signaling and cell proliferation rate of ESCs.
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CHAPTER III – ACTIVATION OF TYPE I INTERFERON SIGNALING IN
DICER KNOCKOUT MOUSE EMBRYONIC STEM CELLS

3.1

Introduction
The innate immune system is the first line of an organism’s defense against a

broad range of pathogen invasions. Although innate immunity consists of different
mechanisms, the antiviral response is one of the most critical components and is
presumably developed in most, if not all, mammalian cells (Kumar et al., 2009; Sen,
2001). However, a series of our recent studies have demonstrated that mouse
embryonic stem cells (ESCs) have an attenuated innate immune response. They do
not express type I interferons (IFN) and lack response to inflammatory cytokines.
Similar observations have been made in human ESCs and induced PSCs (iPSCs)(Guo
et al., 2015; Hong & Carmichael, 2013). Therefore, this is a common property shared
by all types of PSCs. It appears that ESCs in the early embryo are immunologically
divergent from the traditional view of “innate immunity” established in somatic cells
of developed organisms.
The biological implications of the attenuated innate immune responses in
ESCs have been speculated from different perspectives. Immune response is a doubleedged sword: it serves as a critical part of the defense mechanism, but it can also
cause immunologic toxicity to tissues since IFN and inflammatory cytokines
negatively impact cell proliferation and viability (Garcia et al., 2007; Hertzog et al.,
1994; Samuel, 2001). While this could be tolerated by tissues of developed organisms,
it could cause serious damage to ESCs in an early embryo. From this perspective, an
attenuated immunological response could serve as a self-protective mechanism in
ESCs by minimizing immunological cytotoxicity at early stages of embryogenesis
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(Guo, 2019). From the perspective of ESC biology, IFN response does not appear to
be compatible with the pluripotency of ESCs, as demonstrated by a recent study
showing that forced activation of the IFN pathway can cause dysregulation of many
pluripotency- and lineage-specific genes in ESCs (Eggenberger et al., 2019). Both
scenarios are supported by strong experimental evidence and are not mutually
exclusive. However, they only make biological sense if the deficiency in IFN
production does not compromise the defense capacity of ESCs. Indeed, three
alternative antiviral mechanisms have been proposed; ESCs may use a subset of
preexisting IFN-stimulated genes (ISGs) that are independent of IFN stimulation (Wu
et al., 2018), they may use the RNA interference (RNAi) antiviral pathway that may
not be operational in differentiated mammalian cells (Pare & Sullivan, 2014)), or they
may use endogenous reverse transcriptase to produce viral RNA-DNA hybrid
ultimately cleaved by RNase H similar to that of bacterial antiviral CRISPR-CAS
strategy.
Although RNAi is widely recognized as a major antiviral mechanism in
invertebrates, such a function has not been convincingly demonstrated in mammals.
Interestingly, RNAi activity was detected in viral infected mouse ESCs, pointing to
the possibility that RNAi could be an alternative antiviral mechanism in ESCs, in
which the IFN system is deficient (Maillard et al., 2013). However, the physiological
significance of RNAi as an antiviral mechanism in ESCs remains uncertain (Cullen &
Cherry, 2013). Since Dicer is the key enzyme responsible for miRNA and siRNA
biogenesis, D−/−ESCs could be used as a loss-of-function model to investigate the
function of RNAi since they have retained the basic morphology of ESCs and the
capacity to express pluripotency markers even though they display severe
differentiation and growth defects (Kanellopoulou et al., 2005; Murchison et al.,
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2005). Interestingly, it was recently reported that D−/−ESCs were able to express
IFNβ and show increased antiviral activity (Witteveldt et al., 2019). Quite
unexpectedly, our studies using ESCs as a model to express proteins from synthetic
mRNA have led to new insights into the role of Dicer in the regulation of antiviral
responses in these cells. Direct expression of a protein from its synthetic mRNA is an
alternative to plasmid DNA- or viral vector-based gene expression systems (Angel &
Yanik, 2010). A major biological issue with this method is that synthetic mRNA
transfected to the host cells is detected as foreign RNA and elicits antiviral responses,
leading to reduced cell viability and apoptosis of the host cells (Angel & Yanik,
2010). However, this is not a serious problem in ESCs due to their attenuated antiviral
responses as we demonstrated in a recent study (Wang et al., 2014a). Taking
advantage of this feature in ESCs, we attempted to use green fluorescent protein
(GFP) expressed from its synthetic mRNA as a virus-free in vitro assay to determine
RNAi activity in this study. RNAi activity was indeed detected in wild-type ESCs, but
not in D−/−ESCs, as expected. However, D−/−ESCs showed increased antiviral
responses to RNA transfection.
Viral RNA induces IFN response by interacting with Toll-like receptors
(TLRs) and retinoic acid–inducible gene I (RIG-I)-like receptors (RLRs), leading to
IFN transcription through activation of NFκB and IRFs (Fig. 1.2). In addition, viral
RNA can also activate other antiviral mechanisms, such as dsRNA-activated protein
kinase R (PKR). Activation of PKR causes inhibition of both cellular and viral protein
synthesis. While this represses viral replication, it also inhibits cell proliferation (Yan
& Chen, 2012). PKR is constitutively expressed in cells and is readily activated by
viral dsRNA or by dysregulated cellular RNA, but it can be further upregulated by
IFN as a part of the IFN response. Thus, the IFN system can activate multiple
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pathways and mount a powerful antiviral response (Samuel, 2001).
While it is apparent that the deficiency of ESCs in expressing IFN is closely
related to pluripotency, the underlying molecular basis of this deficiency is poorly
understood. Since ESC-specific miRNAs modulates NFκB, the master transcription
factor for IFN pathway ((Luningschror et al., 2012) and expression of genes involved
in IFN pathway are modulated by miRNAs (Sedger, 2013), it is plausible that the
deficiency of miRNA pathway in D-/-ESCs may affect IFN pathway. In addition to
the role of Dicer in miRNA pathway, Dicer also process cellular dsRNA structures,
mostly retrotransposons such as LINE-1 elements, B1 RNA (Babiarz et al., 2008), and
Alu elements which are homologs of B2RNA in humans (Tarallo et al., 2012).
Accumulation of these endogenous dsRNA structures cause inflammatory response
(Kaneko et al., 2011) and activation of PKR (White et al., 2014) leading to unwanted
cellular cytotoxicity. In this study, we demonstrate that D−/−ESCs have gained the
ability to express type I IFN system. Our data revealed a critical role of Dicer as a
repressor of type I IFN signaling in ESCs.

3.2

Methods

3.2.1

Cells and cell culture
The immunological properties of mouse ESCs have been investigated with

two independent cell lines (D3 and DBA252) in our previous studies (Wang et al.,
2013, 2014b). Two pairs of wild-type mouse ESCs (ESCs) and Dicer knockout ESCs
(D−/−ESCs) were used for most experiments to validate the results. They were
designated as ESC1 (D3 cell line, ATCC) and D−/−ESC1 (kindly provided by Dr
Gregory Hannon) (Murchison et al., 2005) and ESC2 and D−/−ESC2 (kindly provided
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by Dr Phillip Sharp) (Calabrese et al., 2007). All ESCs and D−/−ESCs were
maintained in standard mouse ESC medium that contains leukemia inhibitory factor
(LIF) as previously described (Coleman et al., 2004). ESC-differentiated FBs (ESCFBs, differentiated from D3 ESCs) were cultured in ESC medium in the absence of
LIF as previously described (D’Angelo et al., 2016; Wang, et al., 2014b). All cells
were maintained at 37 C in a humidified incubator with 5% CO2.
3.2.2

In vitro synthesis of RNA
Synthetic RNA was prepared by in vitro transcription according to the

methods that have been previously described (Wang et al., 2014a). Briefly, the DNA
template for enhanced GFP mRNA (GFP-mRNA) was generated from a pEGFP-N1
plasmid (BD Biosciences) by PCR using Q5 High-Fidelity DNA polymerase (New
England BioLabs). The resulting dsDNA templates contain the T7 u2.5 promoter for
in vitro transcription (Coleman et al., 2004; Huang, 2003), the 5’-UTR region with a
Kozak sequence (Kozak, 1987), and the open reading frame of GFP. To prepare
functional GFP, in vitro transcription from the DNA templates was carried out in the
presence of the cap analog m7GpppA (chemically synthesized in our lab, unpublished)
to generate 5’-capped GFP-mRNA transcripts. The purified RNA transcripts were
polyadenylated by E. coli Poly(A) polymerase (New England Biolabs), resulting in
functional mRNA, m7GpppA-GFP-polyA (designated as GFP-mRNA).
To prepare double-stranded RNA (dsRNA), To prepare double-stranded RNA
(dsRNA), dsRNA containing 650 nucleotides that nearly encompass the entire length
of GFP-mRNA and dsRNA containing 606 nucleotides of Gausia luciferase mRNA
(simplified as dsGFP and dsLuc, respectively) were prepared by annealing the sense
and antisense RNA transcribed from separate templates of the same sequences but
with a T7 u2.5 promoter in opposite directions, therefore having a perfect dsRNA
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structure. B2RNA is a 178 nucleotide RNA sequence corresponding to the B2 SINE
that is abundantly distributed in the mouse genome (Walters et al., 2009). It can fold
into a secondary structure with five hairpins, two loops, and two single stranded
regions (Espinoza et al., 2007). B2RNA was amplified by PCR from both mouse
genomic DNA and cDNA with the primer pair 5’-GGGCTGGTGAGATG-3’ and 5’AAAG ATTTATTTATTTATTATA-3’. The DNA fragment was cloned into a pB2
plasmid downstream of a T7 promoter by our previously developed in vivo cloning
method (Huang et al., 2017). Restriction digestion by BsaI at the end of the B2
sequence resulted in a linearized DNA molecule, from which B2RNA was
synthesized by transcription with T7 RNA polymerase. Cy3-labeled B2RNA (Cy3B2) was prepared similarly but in the presence of synthetic Cy3-AMP that acts as a
transcription initiator to yield fluorescent RNA (Li et al., 2005).
3.2.3

Cell transfection and treatment
ESCs and D−/−ESCs were plated at 40 to 50% confluence and were usually

cultured for 24 h before the experiments. Synthetic RNA was transfected into the cells
with Endofectin Max (Genecopoeia) at 300 ng/ml for GFP-mRNA, B2RNA, and
polyIC (Sigma-Aldrich) and 200 ng/ml for dsGFP and dsLuc, or at the concentrations
specified in individual experiments. The imidazolo-oxindole PKR inhibitor (C16,
Sigma-Aldrich) was used to inhibit PKR activity as previously described (Wang et al.,
2013). To determine the effects of secreted IFNβ on ESCs and D−/−ESCs transfected
with RNA, the cells were incubated with IFNβ-neutralizing antibodies or isotype
control antibodies (BioLegend) for 30 min prior to RNA transfection. The cellular
responses to type I IFN were determined with mouse recombinant IFNα
(eBioscience). The treated cells were collected and used for various analyses under
conditions described in individual experiments.
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3.2.4

Preparation of conditioned medium (CM) and ELISA analysis of IFNβ
CM preparation was carried out with protocols previously described

(D’Angelo et al., 2018). Briefly, ESCs and D−/−ESCs were transfected with dsGFP
(200 ng/ml). After 4 h, the medium was removed, and cells were thoroughly washed
with PBS. The cells were then cultured in DMEM that contains 15% FBS for an
additional 24 h. CM prepared from cells without transfection with dsGFP was used as
control CM. The CM was collected and centrifuged at 10,621g for 15 min, and the
supernatants were collected and used for the treatment of ESC-FBs. To analyze IFNβ
secreted to the culture medium, ESCs and D−/−ESCs were transfected with dsGFP (1
μg/ml) in serum free medium with 0.2% BSA. After 24 h, the culture medium was
collected, concentrated with a centrifugal concentrator (10 kDa cutoff), and analyzed
for IFNβ protein using a quantitative mouse ELISA kit (BioLegend) according to the
manufacturer’s instruction.

3.2.5

Microscopy and flow cytometry analysis of GFP expression
Cell morphology and viability were routinely monitored with an Olympus

CKx31 phase-contrast microscope during the time course of treatment. Expression of
GFP in live cells was visualized using a Leica fluorescence microscope (DFC3000G).
The images were acquired with a digital camera mounted on the microscope. The cell
population expressing GFP was quantitatively determined by flow cytometry with an
Accuri C6 flow cytometer (BD Biosciences) (Wang et al., 2014a). Cell gating was
performed by selecting the cell population from forward versus side scatter (FSC
versus SSC) dot plots to exclude debris. Histograms that represent GFP expression
levels were generated from median fluorescence intensities of analyzed samples with
CFlow software (BD Biosciences) as previously described (Wang et al., 2014a).
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3.2.6

Western blot analysis
Protein analysis by Western blot was performed according to our published

method (Wang et al., 2013). The antibodies against β-Actin, STAT1, PKR, pPKR,
p19, p21, CDC25A, and CDK2 were purchased from Santa Cruz Biotechnology and
peIF2α antibodies were from Cell Signaling Technology.

3.2.7

Real-time quantitative polymerase chain reaction (RT-qPCR)
Total RNA was extracted using Tri-reagent (Sigma). cDNA was prepared by

MMLV reverse transcriptase (Promega). RTqPCR was performed using SYBR green
ready mix on an MX3000PTM RT-PCR system (Stratagene), as previously reported
(Guo et al., 2007). The mRNA level from RT-qPCR was calculated using the
comparative Ct method (Pfaffl, 2001). β-Actin mRNA was used to normalize relative
levels of mRNA for tested genes. The sequences of the primer sets are listed in Table
1.
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Table 1. Table showing list of primers used for RT-qPCR

Gene
β-Actin
PKR
RIG-I
MDA5
IFNβ
ISG15
B2 RNA
IFNAR1
IFNAR2
JAK1
TyK2
STAT1
STAT2
p16
p19
p21
Cyclin E1
Cyclin A2
Cyclin B1

3.2.8

Forward primer (5’-3’)
CATGTACGTAGCCATCCAGGC
AAGCAGGAGGCAAGAAACG
ATTCAGGAAGAGCCAGAGTGTC
CGATCCGAATGATTGATGCA
CCCTATGGAGATGACGGAGA
AGGTCTTTCTGACGCAGACTG
GAGTTCAAATCCCAGCAACCA
GACAACTACACCCTAAAGTGGAG
TGTCTGCGAGCCTAGAGACTA
ACGCTCCGAACCGAATCATC
TGCATCCACATCGCACACAA
GCTGCCTATGATGTCTCGTTT
CTGAAGGACGAACAGGATGTC
CGCAGGTTCTTGGTCACTGT
ATGCTGGATTGCAGAGCAGTA
CGAGAACGGTGGAACTTTGAC
CCTCCAAAGTTGCACCAGTTTGC
CAGTCACAGGACAGAGCTGG
CGAGAACTGCTCTTGGAGACATTG

Reverse primer (5’-3’)
CTCTTTGATGTCACGCACGAT
TGACAATCCACCTTGTTTTCGT
GTCTTCAATGATGTGCTGCAC
AGTTGGTCATTGCAACTGCT
ACCCAGTGCTGGAGAAATTG
GGGGCTTTAGGCCATACTCC
TACACTGTAGCTGTCTTCAGACA
GCTCTGACACGAAACTGTGTTTT
AGCCGGGAATTTCGTATTGTTAT
GTGCCAGTTGGTAAAGTAGAACC
CTCCTGGGGATTCATGCCA
TGCTTTTCCGTATGTTGTGCT
CAGGGTGGTTAATCGGCCAA
TGTTCACGAAAGCCAGAGCG
ACGGGGCACATTATTTTTAGTCT
CAGGGCTCAGGTAGACCTTG
GACACACTTCTCTATGTCGCACC
GGGCATGTTGTGGCGCTTTG
CCTGACACAGATACTCTTCTGCAG

Cell viability analysis
The viability of ESCs and D−/−ESCs was determined by cell number and by

cell morphology after toluidine blue (TB) staining. The absorbance at 630 nm of TBstained cells was measured with a microtiter plate reader. The values, which correlate
with the number of viable cells, were used as an indirect measurement of cell
proliferation or viability.
3.2.9

Statistical analysis
Statistical analysis was performed with Microsoft Excel using a two-tailed and

unpaired Student’s t-test. Data are presented as the mean ± SD under specified
experimental conditions. Statistical differences are indicated by p-values. p < 0.05*
was considered statistically significant. p values up to four significant digits are
shown as specified in figure legends.
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3.3

Results

3.3.1

Validation of Dicer knockout mouse embryonic stem cells (D-/-ESCs)
For our study, we used two D-/-ESC cell lines. In both of these cell lines, the

nucleotide sequence encompassing the dsRNA cleaving kinase domains of Dicer
RNaseIIIa and RNase IIIb has been deleted (Fig. 3.3.1 A). Dicer protein was not
detected in both D-/-ESC cell lines, whereas the protein was detected in both ESC cell
lines (Fig. 3.3.1 B). This result validated the D-/-ESC cell lines.

Figure 3.3.1. Detection of Dicer protein in ESCs. A, Schematic representation of helicase,
DUF, PAZ, RNase, and dsRBD domains of Dicer gene highlighting the region of deletion in D-/-ESCs.
B, Western blot showing expression of Dicer protein in both cell lines of ESCs and D-/-ESCs. β-Actin
serves as loading control. The experiment was repeated at least three times with similar results.

3.3.2

Development of an RNA-based assay to determine different antiviral

responses in ESCs.
This assay was initially intended to determine the RNAi activity in ESCs.
Functionalized GFP-mRNA was first transfected into cells where it was translated to
GFP. The cells were then transfected with a synthetic dsRNA corresponding to the
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sequence of GFP (designated as dsGFP). Based on the principle of RNAi, dsGFP
would be processed to yield siRNA that will specifically target GFP-mRNA, thereby
reducing GFP expression. GFP was detected as early as 3 h after GFP-mRNA
transfection. Subsequent transfection with either dsGFP or dsLuc (a control luciferase
dsRNA of similar length with a sequence unrelated to GFP-mRNA) reduced GFP
expression as indicated by diminished green fluorescence (Fig. 3.3.2 A). Quantitative
analysis by flow cytometry indicated that GFP fluorescence intensity in ESCs was
reduced more by dsGFP than by dsLuc (Fig. 3.3.2 B), 59% versus 76% at 24 h, in
comparison with control, 100%). However, in D−/−ESCs, both dsGFP and dsLuc
reduced the expression of GFP to a similar level (45% versus 47%, at 24 h). A logical
explanation for these results would be that the different effect between dsGFP and
dsLuc in ESCs is due to sequence-specific reduction of GFP-mRNA by dsGFP via
Dicer-dependent RNAi activity, which is abolished in D−/−ESCs. The non-sequencespecific effects in the reduction of GFP fluorescence caused by dsGFP and dsLuc in
both ESCs and D−/−ESCs are likely due to the activation of other pathways.
These results demonstrated the existence of RNAi activity in ESCs, which
agrees with the study using GFP expressed from plasmids as an siRNA target
(Maillard et al., 2016). However, the most notable observation is that transfection of
D−/−ESCs with dsRNA, and to a lesser extent with GFP-mRNA, caused cell death, as
judged by the increased number of detached cells (Fig. 3.3.2 A, D−/−ESC1), whereas
the cytotoxicity caused by dsRNA transfection in ESCs is low and limited to reduced
colony size (Fig. 3.3.2 A, ESC1). These results suggested that D−/−ESCs have
increased susceptibility to the cytotoxicity of transfected RNA. The GFP-mRNA
contains some uncapped GFP-mRNA, which has a 5’ppp-group that can activate RIGI (Schlee et al., 2009). Therefore, the RNA preparations used in the above
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experiments can potentially interact with most, if not all, known RNA receptors,
including TLR3, RIG-I, MDA5, and PKR, that can potentially activate most of the
common antiviral pathways. Therefore, cellular effects of RNA transfection on ESCs
and D−/−ESCs represent the collective results of their antiviral responses. The
increased antiviral response in D−/−ESCs is a novel finding that we investigated
further with two independent pairs of ESC lines (ESC1; D−/−ESC1 and ESC2;
D−/−ESC2) in this study.
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Figure 3.3.2. Determining RNAi activity using GFP as a target in ESC1 and D/-ESC1. Cells were first transfected with GFP-mRNA. After 3-5 h, the cells were then transfected
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with dsGFP or dsLuc. Cells transfected with GFP-mRNA only were used as the control (Con). The
cells were cultured for an additional 24 h or 48 h. GFP expression and the effects of dsGFP and
dsLuc were analyzed by microscopy (A, 24 h) or by flow cytometry (B, 24h and 48 h). Fluorescnce
(Flu) intensity represents the relative levels of GFP expression. The number of GFP positive cells in
the control (Con) was set to 100%. Cells without any transfection were set to 0% as the baseline. The
bar graphs show the median GFP Flu intensities of tested samples shown in the histograms. For D-/ESC1, the data were from cells of two independent experiments that were cultured for 24 h after
transfection with dsGFP and dsLuc. D-/-ESC1 that were cultured for 48 h could not be analyzed due
to strong cytotoxicity caused by RNA transfection. All experiments were repeated at least twice with
similar results.

3.3.3

D−/−ESCs have increased capacity to express type I IFN
To determine the effect of Dicer deletion on the IFN pathway, we transfected

the cells with dsGFP or dsLuc and analyzed the expression of IFNβ and ISG15 as
indicators of the functionality of the type I IFN system. As shown in Figure 3.3.3.1 A,
the mRNA levels of the two genes were not or only slightly increased in ESCs, but
they were strongly stimulated in D−/−ESCs. Similar results were observed when cells
were transfected with polyIC (polyinosinic-polycytidylic acid), a synthetic dsRNA
used as a viral RNA analog in our previous studies (Wang et al., 2013, 2014b) (data
not shown).
It is known that certain cellular RNA with dsRNA structures, including those
from apoptotic cells, misprocessed RNA, and transcripts of transposable elements
(TEs), can induce antiviral responses and cause cellular damage in the absence of
infection (Wang & Carmichael, 2004; White et al., 2014; Williams, 1999). The B2
short interspersed nuclear element (SINE) is a major type of retrotransposons in
mouse genomes (Walters et al., 2009). B2RNA, which has several features of dsRNA
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(Espinoza et al., 2007), is abundantly expressed in mouse ESCs. As shown in Figure
3.3.3.1 B, synthetic B2RNA (B2) showed patterns like dsGFP and dsLuc in inducing
IFNβ and ISG15 expression in ESCs and D−/−ESCs. It is noted that the endogenous
B2RNA level in D−/−ESCs was significantly higher than in ESCs, indicating its
accumulation in D−/−ESCs (Fig. 3.3.3.1 C). If Dicer is responsible for processing
endogenous B2RNA, it could target the transfected B2 RNA as well. To test this
possibility, we transfected ESCs and D−/−ESCs with Cy3-labeled fluorescent
B2RNA (Cy3-B2) and analyzed the levels of Cy3-B2 by Cy3 fluorescence intensity.
Our results indicated that Cy3-B2 was detected at higher levels in D−/−ESCs than in
ESCs (Fig. 3.3.3.2), consistent with the accumulation of endogenous B2RNA in
D−/−ESCs (Fig. 3.3.3.1 C). We also compared the basal mRNA levels of the RNA
receptors that mediate the effects of viral RNA. Except for MDA5, which is expressed
at higher levels in D−/−ESCs than in ESCs, the other tested dsRNA receptors are
expressed at comparable levels (Fig. 3.3.3.1 D).
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Figure 3.3.3.1. dsRNA- and B2RNA-induced expression of IFNβ and ISG15 in
ESCs and D−/−ESCs. ESCs and D−/−ESCs were transfected with dsRNA or B2RNA for the
indicated time periods. The mRNA levels of the tested genes were determined by RT-qPCR. A, dsGFPand dsLuc-induced IFNβ and ISG15 mRNA. B, B2RNA-induced IFNβ and ISG15 mRNA. C, relative
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cellular levels of B2RNA in ESCs and D−/−ESCs. D, Comparison of the basal mRNA levels of dsRNA
receptors in ESCs and D−/−ESCs. For A and B, the mRNA level of each tested gene in the control
ESCs (Con) is designated as 1. For C and D, the basal mRNA level of each tested gene in ESCs is
designated as 1. The values are as mean ± SD of three independent experiments (A and D) or a
representative experiment performed in biological triplicate that was performed at least twice (B and
C). p < 0.0001,****; p < 0.001,***; p < 0.01,**; p < 0.05.* Compared groups are indicated by a
horizontal bar.

Figure 3.3.3.2. Reduced degradation of B2RNA in D-/-ESC2. A, ESC2 and D-/ESC2 were transfected with 400 ng/ml of Cy3-labelled B2RNA (Cy3-B2) and examined under a
fluorescence microscope at indicated times. Con represents the cells without Cy3-B2 transfection.
The images are from a representative experiment that was repeated twice with similar results. B,
Total RNA (3μg) extracted from the treated cells was analyzed by agarose gel electrophoresis. Cy3B2 was identified by Cy3-fluorescence, and 18S rRNA was stained with ethidium bromide. The
images were obtained by a phosphorimager (Bio-Rad, Molecular Imager FX). C, The relative amount
of Cy3-B2 in ESC2 and D-/-ESC2 shown in B was quantified by the fluorescence intensity of Cy3-
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B2 normalized to that of 18S rRNA using ImageJ software. The value in ESC2 was defined as 1. The
values are as mean ± SD of a representative experiments performed in biological triplicate that were
performed at least twice. P<0.0001,****; P<0.001,***; P<0.01,**; P<0.05.* Compared groups are
indicated by a horizontal bar.

3.3.4

D−/−ESCs have a functional type I IFN system
ESCs can respond to IFNα and IFNβ, but they are unable to express the two

cytokines (Wang et al., 2013, 2014b). To test if Dicer deletion affects the
responsiveness of ESCs to IFN, we treated the cells with IFNα and compared IFNαinduced expression of three ISGs (PKR, ISG15, and STAT1) in ESCs and D−/−ESCs.
IFNα induced expression of all three genes, with ISG15 mRNA induced significantly
higher in D−/−ESCs than in ESCs (Fig. 3.3.4 A). It is also noted that the basal mRNA
levels of all three ISGs are about threefold higher in D−/−ESCs than in ESCs. At the
protein level, STAT1 was detected in unstimulated cells, but it was induced by IFNα
in both ESCs and D−/−ESCs. IFNα-induced PKR was also apparent in ESCs and
D−/−ESCs (Fig. 3.3.4 B, left panel).
For a functional analysis of the IFN system, we prepared conditioned medium
(CM) from dsGFP-transfected ESCs and D−/−ESCs (dsGFP[CM]). The rationale is
that if the CM contains IFN, it will induce ISGs, such as STAT1, resembling the
effects of IFNα (Fig. 3.3.4 B). In this experiment, we used ESC-differentiated
fibroblasts (ESC-FBs) since they are much more responsive to IFN than ESCs
(D’Angelo et al., 2016). As shown in figure 3.3.4 C, dsGFP[CM] prepared from
D−/−ESCs, but not that from ESCs (blot inset), induced the expression of STAT1 in
ESC-FBs. This result indicated that dsGFP[CM] only from D−/−ESCs contains
secreted IFN, as confirmed by ELISA analysis of IFNβ in the CMs (Fig. 3.3.4 C, bar
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graph). Together, these data demonstrate that D−/−ESCs have a fully functional type I
IFN system.
We further analyzed the expression levels of the major signaling molecules
that mediate the effects of IFN. As shown in Fig. 3.3.4 D, RT-qPCR analysis
indicated that most of these molecules were expressed at comparable mRNA levels in
ESCs and D−/−ESCs although some variations were noted for JAK1, IFNAR2, and
STAT1 between the two different D−/−ESC lines.
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Figure 3.3.4. IFN responses in ESCs and D−/−ESCs. A, RT-qPCR analysis of IFNα (500
units/ml)-induced PKR, ISG15, and STAT1 expression. The mRNA level of each tested gene in the
control ESCs (Con) is designated as 1. B, western blot analysis of IFNα-induced expression of STAT1
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and PKR. C, blot inset, conditioned medium (CM)-induced expression of STAT1. ESC-FBs were
treated for 24 h with Con[CM] (prepared from ESCs and D−/−ESCs without dsGFP transfection) and
dsGFP[CM] (prepared from ESCs and D−/−ESCs transfected with dsGFP). Con, cells without any
treatment. Bar graph, ELISA analysis of IFNβ in the medium secreted by ESCs and D−/−ESCs in
response to dsGFP. D, RT-qPCR analysis of the basal mRNA levels of signaling molecules that
mediate the effects of type I IFN in ESCs and D−/−ESCs. The basal mRNA level of each tested gene in
ESCs is designated as 1. In bar graphs, the values are as mean ± SD of three independent experiments
(C and D) or a representative experiment performed in biological triplicate that was performed at least
twice (A). p < 0.0001,****; p < 0.001,***; p < 0.01,**; p < 0.05.* Compared groups are indicated by a
horizontal bar. In Western blot analysis, the blots are representatives from experiments that were
repeated three times. β-Actin was used as a reference for protein loading.

3.3.5

The contributions of IFNβ to the cytotoxicity of transfected RNA in

D−/−ESCs.
In routine cell culture, it is notable that there are more cells undergoing
spontaneous cell death in D−/−ESCs than in ESCs. In particular, D−/−ESCs are more
susceptible than ESCs to the cytotoxicity of RNA transfection as shown in Fig. 3.3.2
A. By quantitatively analyzing the number of viable cells after transfection with
different concentrations of dsRNA, our results demonstrated that D−/−ESCs are more
sensitive to the cytotoxicity of dsGFP and dsLuc at all concentrations tested (Fig.
3.3.5 A). We had previously reported that IFNα or IFNβ alone does not have
detectable effects on proliferation and viability of ESCs (Wang et al., 2013, 2014b) or
D−/−ESCs under normal conditions (data not shown). To determine the contribution
of IFNβ to the cytotoxicity in the cells transfected with RNA, we first preincubated
ESCs and D−/−ESCs with IFNβ-neutralizing antibodies, followed by cell transfection
with dsRNA. The rationale of this experiment is that the activity of IFNβ secreted by
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the cells will be neutralized by the antibodies before its autocrine signaling action. As
shown in Fig. 3.3.5 B, neither IFNβ-neutralizing antibodies nor control antibodies
affect the effect of dsRNA on ESC viability. However, IFNβ neutralizing antibodies,
but not control antibodies, significantly reduced the cytotoxicity of dsGFP and dsLuc
on D−/−ESCs (Fig. 3.3.5 B). Similar results were observed when the cells were
transfected with polyIC or B2RNA (data not shown). These results suggested that
IFNβ contributes to the cytotoxicity only in D−/−ESCs in which it can be produced,
but not in ESCs that are deficient in expressing this cytokine.
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Figure 3.3.5. Contribution of IFN response to the cytotoxicity caused by RNA
transfection in ESCs and D−/−ESCs. A, effects of dsGFP and dsLuc transfection on cell
viability. B, IFNβ-neutralizing antibodies reduced cytotoxicity caused by dsGFP and dsLuc transfection
in ESCs and D−/−ESCs. Cells were preincubated with control isotype antibodies (Ab, Con) or IFNβneutralizing antibodies (Ab, IFN) (2 μg/ml) for 30 min followed by transfection with dsGFP or dsLuc.
The cell viability was determined after 24 h incubation. The cell number in the control (Con, cells
without any treatment) was set as 100%. In all experiments, the values are as mean ± SD of a
representative experiments performed in biological triplicate that were performed at least twice. p <
0.0001,****; p < 0.001,***; p < 0.01,**; p < 0.05*. Compared groups are indicated by a horizontal bar.

3.4

Discussion
Using GFP expressed from its synthetic mRNA as an siRNA target, we

detected Dicer-dependent RNAi activity in ESCs, a conclusion like the results
reported in a study using GFP expressed from a plasmid (Maillard et al., 2016).
However, the features of synthetic RNA as viral RNA analogs allowed us to reveal
strikingly different antiviral responses between ESCs and D−/−ESCs. Namely, Dicer
deficiency leads to the acquisition of the ability to express type I IFNs in D−/−ESCs.
It potentially makes D−/−ESCs more susceptible to the cytotoxicity associated with
antiviral responses, either from viral RNA or from misprocessed cellular RNA. These
findings not only provide important insights into the molecular basis underlying the
phenotypes of D−/−ESCs, but also reveal the biological function of Dicer in the
regulation of ESC immunological properties, pluripotency, and proliferation.
Since the deficiency in expressing type I IFN is a common feature of all types
of pluripotent cells, it appears that this is an intrinsic feature inherently related to the
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pluripotent state (Guo et al., 2015). However, findings from this study further suggest
that lack of IFN expression in ESCs is not entirely restricted by pluripotency, but it is
also repressed by Dicer since D−/−ESCs have retained ESC morphology and
pluripotency marker expression and in fact fail to exit the pluripotent state
(Kanellopoulou et al., 2005; Murchison et al., 2005). These features presumably made
D−/−ESCs a seemingly useful model to study RNAi in mammalian cells in the
pluripotent state with an underdeveloped IFN antiviral system. However, it is quite
surprising to find that D−/−ESCs have gained the ability to express type I IFN as we
demonstrated in this study and in a recent report in which increased activity against
viral infection was also noted in D−/−ESCs by other investigators (Witteveldt et al.,
2019). This finding renders D−/−ESCs as an undesirable model system to study RNAi
antiviral activity in ESCs as we previously intended.
While the molecular mechanisms underlying how D−/−ESCs have gained the
ability to produce type I IFN remain to be determined, we can logically assume that
deficiency in miRNA biogenesis would be a primary reason. In particular, ESCs
express a distinct set of miRNAs, known as ESC-specific miRNA (ESC-miRNA), that
are critical for the maintenance of the stem cell state (Tiscornia & Belmonte, 2010).
Although we have rather limited knowledge about the miRNA that specifically
controls the innate immunity of ESCs, the most relevant findings are that two
members of the miR-290 cluster of ESCmiRNA, miR-291b-5p, and miR-293, directly
target the mRNA of the RelA subunit of NFκB (Luningschror et al., 2012). This could
contribute to the inactive state of NFκB in ESCs since NFκB and IRFs are the key
transcription factors that control IFN expression (Napetschnig & Wu, 2013). Indeed,
both NFκB and IRF3 can be activated in D−/−ESCs by polyIC, but not in ESCs
(Witteveldt et al., 2019). Furthermore, mitochondrial antiviral signaling protein
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(MAVS), a signaling molecule that regulates IFN expression, was identified as a
target of miR-673 in ESCs as reported in a recent study (Witteveldt et al., 2019).
Likewise, defining the precise contributions of IFN responses to the phenotype of
D−/−ESCs is also challenging since IFN can exert their effects in numerous ways.
Nonetheless, the results from the experiments with IFNβ-neutralizing antibodies
demonstrate that IFNβ (and likely the other members of type I IFN) can potentiate the
cytotoxic effect of dsRNA, which could, at least partly, act through the induction of
de novo synthesis of PKR or other ISGs.
The observation that D−/−ESCs can express type I IFN is quite noticeable
since normal ESCs do not produce these cytokines. We are not aware of studies that
specifically analyze the effect of Dicer knockout on IFN response in differentiated
somatic cells. However, it has been reported that Dicer knockdown with siRNA in
endometrial cancer cells resulted in an increased IFN response (Chiappinelli et al.,
2012). These findings suggest that Dicer may share similar functions in ESCs and
differentiated cells. However, Dicer may play unique and prominent roles in ESCs in
which preventing antiviral is fundamentally important for the normal growth and
development of an early embryo.
In summary, the data presented in this study further support the hypothesis
that antiviral responses could negatively impact ESC function. We have identified
Dicer as a repressor of the IFN system in ESCs at the pluripotent state. However, it
should be pointed out that Dicer regulates numerous cellular processes, directly or
indirectly. The specific mechanisms that lead to the acquisition of the ability to
express type I IFN remain to be determined.
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CHAPTER IV – CONSTITUTIVE ACTIVATION OF DOUBLESTRANDED RNA-ACTIVATED PROTEIN KINASE (PKR) IN D-/-ESCs
INHIBITS CELL PROLIFERATION

4.1

Introduction
One of the unique characteristics of ESCs is their high proliferation rate

compared to differentiated somatic cells. Mouse ESCs undergo mitosis cell division in
every 6-8 hours (Wang & Alexander, 2011). However, the doubling time of somatic
cells are much longer depending upon the cell type. Interestingly, D-/-ESCs have
reduced proliferation rate than ESCs (Murchison et al., 2005). It has been shown that
ESC specific miRNAs are partly responsible for the reduced proliferation since D-/ESCs do not have functional miRNA pathway. Moreover, the protein levels of cell
cycle inhibitors such as P16 and P21 were higher in D-/-ESCs compared to ESCs
(Wang et al., 2008). However, in addition to the role of Dicer in miRNA pathway,
Dicer also process long non-coding RNA and SINEs (Babiarz et al., 2008; Bodak et
al., 2017) and their role in cell cycle needs further investigation. We saw higher basal
levels of B2RNA and exogenous transfected B2RNA retains more in D-/-ESCs. These
B2RNA are 178 nucleotides long and exist as stem-loop dsRNA structure inside the
cells. They can be bound to and activate various dsRNA receptors. In ESCs, PKR is
the only functional dsRNA receptor (Wang et al., 2013), and given the fact that PKR
can be activated by dsRNA as less as 30bp long, it is more likely that PKR can be
activated by B2RNA. To prevent the activation of dsRNA receptors which are present
in the cytoplasm, these cellular dsRNA structures are confined in the nucleus (Chen &
Carmichael, 2009). However, during mitotic stage of cell division, since the nuclear
membrane is disintegrated, they can activate their cognate receptors. In fact, it has
54

been shown that during mitotic stage, these dsRNA structures activate PKR. The
activated PKR inhibits translation initiation and promotes condensation of chromatins
thus helping cells during mitosis (Kim et al., 2014). Hence, PKR has an important role
during cell division, although it has been studied extensively as an antiviral protein.
Hence, the level of PKR activation should be finely tuned for maintaining normal cell
cycle profile in ESCs. The role of Dicer here is to control the activation of PKR by
cleaving dsRNA structures to short dsRNA (about 21bp) so that they can no longer
activate PKR. Recently, it has also been shown that the N-terminal helicase domain of
Dicer can bind to PKR and prevent its activation (Montavon et al., 2021). It seems
that Dicer maintains desirable levels of PKR activation during cell division. Since in
D-/-ESCs, the level of these dsRNA structures is higher (Babiarz et al., 2008; Bodak
et al., 2017) and together with the absence of Dicer to modulate the activation of PKR,
the unique cell cycle profile of ESCs is distorted. Here, our research focusses on the
role of PKR in slowed proliferation rate of D-/-ESCs by using both dsRNA and
B2RNA as activators of PKR. In this study, we demonstrate that D−/−ESCs have
gained the ability to express constitutively active PKR, which contribute to the
reduced cell proliferation and cell viability of D−/−ESCs.

4.2

Methods
4.2.1

Cells and cell culture

Discussed in section 3.2.1
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4.2.2

In-vitro synthesis of RNA

Discussed in section 3.2.2

4.2.3

Cell transfection and treatment

Discussed in section 3.2.3

4.2.4

Western Blot

Discussed in 3.2.6

4.2.5

Real-time quantitative polymerase chain reaction (RT-qPCR)

Discussed in 3.2.7

4.2.6

Cell viability and cell cycle analysis

The viability of ESCs and D−/−ESCs was determined by cell number and by
cell morphology after toluidine blue (TB) staining. The absorbance at 630 nm of TBstained cells was measured with a microtiter plate reader. The values, which correlate
with the number of viable cells, were used as an indirect measurement of cell
proliferation or viability. Cell cycle analysis was performed with an LSRFortessa flow
cytometer (BD Biosciences) after the cells were stained with 50 μg/ml propidium
iodide. The cell cycle profiles were generated using FlowJo software.

4.2.7

SiRNA transfection and PKR knockdown

SiRNA targeting PKR and negative control siRNA (Santa Cruz
Biotechnology) were transfected to the cells with Endofectin Max at a final
concentration of 100 nM. The cells were then analyzed for siRNA knockdown
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efficiency and the effect on cell proliferation under the specified experimental
conditions.

4.2.8

Statistical analysis
Discussed in 3.2.9

4.3

Results

4.3.1

The PKR pathway is constitutively active in D−/−ESCs
The PKR pathway is functional in ESCs as we demonstrated with polyIC

transfection and viral infection (Wang et al., 2013). To determine if this pathway is
also altered in D−/−ESCs, we treated the cells with dsGFP or B2RNA. Although
dsRNA is the best characterized activator of PKR, single-stranded RNA having
hairpin structures with a certain length can also activate PKR (White et al., 2015).
Therefore, we speculated that B2RNA may be able to activate PKR since it has a
secondary structure with five hairpins, two loops, and two single-stranded regions
(Cullen & Cherry, 2013). PKR activation is commonly assessed by the
phosphorylation of eukaryotic initiation factor 2α (peIF2α), which is a wellcharacterized PKR substrate (Garcia et al., 2007), and by the level of phosphorylated
PKR (pPKR), which is the active form of PKR. As shown in Figure 4.3.1, peIF2α was
detected in both ESCs and D−/−ESCs treated with dsGFP and B2RNA, but levels of
pPKR were much higher in D−/−ESCs than in ESCs. However, the most notable
observation is that both pPKR and peIF2α were detected in untreated D−/−ESCs but
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barely detected in untreated ESCs (Fig. 4.3.1 Con), indicating that PKR is
constitutively active in D−/−ESCs.

Figure 4.3.1. PKR activation in ESCs and D−/−ESCs. Cells were transfected with
dsGFP or B2 RNA for 6 h and 24 h. PKR activation was determined by the levels of
phosphorylated eIF2α (peIF2α, a substrate of PKR) and phosphorylated (activated) PKR (pPKR) with
Western blot. β-Actin was used as a reference for protein loading. The blots are representatives from
experiments that were repeated three times.

4.3.2

D−/−ESCs have reduced cell proliferation rate and express high levels of cell

cycle inhibitors.
ESCs are characterized by their rapid cell proliferation rate due to
constitutively activated cyclin-dependent kinases (CDKs) driven by high expression
levels of cyclins A, B, and E (Stead et al., 2002). D−/−ESCs have a substantially
lower growth rate than ESCs (Fig. 4.3.2 A). RT-qPCR analysis indicated that the
mRNA level of cyclin E and cyclin B appeared to be lower in D−/−ESCs than in
ESCs while cyclin A was not significantly altered. However, three major cell cycle
inhibitors, p21, p19, and p16, which are expressed at very low levels in ESCs, are
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expressed at substantially higher levels in D−/−ESCs (Fig. 4.3.2 B). These results
explain, at least partially, the reduced cell proliferation in D−/−ESCs.

Figure 4.3.2. Analysis of cell proliferation and cell cycle regulator expression in
ESCs and D−/−ESCs. A, cell proliferation analysis. Cells were seeded at about 30% confluence in
a 48-well plate. The cell numbers at the indicated time points were determined by cell viability assay.
The cell number at day 1 for both ESCs and D−/−ESCs is set as 1. B, RT-qPCR analysis of mRNA
levels of cell cycle regulators. The basal mRNA level of each tested gene in ESCs is designated as 1.
The values are as mean ± SD of three independent experiments (B) or a representative experiment
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performed in biological triplicate that was performed at least twice (A). p < 0.0001,****; p <
0.001,***; p < 0.01,**; p < 0.05.* Compared groups are indicated by a horizontal bar.D−/−ESCs.

4.3.3

Contribution of PKR activation in reduced proliferation of D-/-ESCs.
PKR activation is known to inhibit cell proliferation, including in ESCs as we

previously demonstrated with polyIC activated PKR (Wang et al., 2013). To test if
constitutively activated PKR in D−/−ESCs contributed to their reduced cell
proliferation, we treated ESCs and D−/−ESCs with an imidazolo-oxindole PKR
inhibitor (C16), which shows a similar effect to siRNA that knocks down PKR (Wang
et al., 2013). As shown in Figure 4.3.3.1 A, C16 treatment significantly increased the
cell number of D−/−ESCs in a dose dependent manner with the maximal effect at the
concentration of 0.75 μM, but this dose dependence was not seen in ESCs. We further
analyzed the cells by flow cytometry. ESCs have large populations at the S phase and
similar cell populations at the G1 and G2 phases when they are grown at low density.
However, in comparison, D−/−ESCs have increased G1 cell populations and reduced
S phase cell populations, which are indicators of slowed cell cycle progression.
Treatment of D−/−ESCs with C16 reduced the G1 cell population. At 0.75 μM and 1
μM, C16-treated D−/−ESCs have a cell cycle profile with a ratio of G1 and G2 cells
like ESCs. Although the S phase cell population in ESCs was slightly reduced by C16,
the overall cell cycle profiles were not altered (Fig. 4.3.3.1 B), consistent with the
unchanged cell proliferation rate (Fig. 4.3.3.1 A). The effect of C16 on the inhibition
of PKR was confirmed by knocking down PKR expression with its specific siRNA,
leading to increased cell proliferation like the effect of C16 (C).
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In line with the results from RT-qPCR analysis shown in Fig. 4.3.2 B, western blot
analysis indicated that p21 and p19 proteins were expressed at substantially higher
levels in D−/−ESCs than in ESCs, but their relative levels were not affected by C16
(Figure 4.3.3.2 A). The relative levels of CDK2 (Figure 4.3.3.2 B) and cyclin E and A
were not significantly altered in either D−/−ESCs or ESCs by C16 treatment (data not
shown). However, CDC25A, a protein phosphatase that activates CDKs and leads to
G1/S cell cycle progression (Shen & Huang, 2012), is upregulated in D−/−ESCs
(Figure 4.3.3.2 B). This result could contribute to the reduction of G1 phase cells by
C16 in D−/−ESCs.
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Figure 4.3.3.1 Effects of PKR inhibition on cell proliferation and cell cycle of
ESCs and D−/−ESCs. A, cells were seeded at about 30% confluence and cultured in the absence
(Con) or presence of PKR inhibitor C16 at the indicated concentrations. The cell numbers were
determined by cell viability assay after 60 h incubation. The cell number in the control (Con) was set as
100%. B, cells were treated under the conditions as described in A for 48 h. Cell cycle was analyzed by
flow cytometry. Insets show percentages of cell populations in different phases. Arrows denote the
changes of G1 phase cells in control and C16 (1 μM)-treated cells. The histograms are representatives
of flow profiles from experiments that were repeated three times with similar results. C, cells were
transfected with siRNA against PKR (siPKR) or control siRNA (siCon). After 48 h incubation, the cell
number was determined by the method described in A. The number of cells without transfection (Con)
was set as 100%. PKR knockdown is assessed by Western blot analysis. The blot inset shows two sets
of independent samples. In bar graphs, the values are as mean ± SD of a representative experiment
performed in biological triplicate that was performed at least twice (A) or the mean ± SD of two
combined independent experiments each performed in biological triplicate (C). p < 0.0001,****; p <
0.001,***; p < 0.01,**; p < 0.05.* Compared groups are indicated by a horizontal bar.
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Figure 4.3.3.2. Effects of PKR inhibition on the expression of cell cycle
regulators. Cells were treated with different concentrations of C16 for 24 h and analyzed by Western
blot. β-Actin was used as a reference for protein loading. The blots are representatives from
experiments that were repeated three times with similar results.

4.3.4

The contributions of PKR to the cytotoxicity of transfected RNA in

D−/−ESCs.
In routine cell culture, it is notable that there are more cells undergoing
spontaneous cell death in D−/−ESCs than in ESCs. In particular, D−/−ESCs are more
susceptible than ESCs to the cytotoxicity of RNA transfection as shown in Figure
3.3.2 A. By quantitatively analyzing the number of viable cells after transfection with
different concentrations of dsRNA, our results demonstrated that D−/−ESCs are more
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sensitive to the cytotoxicity of dsGFP and dsLuc at all concentrations tested (Fig.
3.3.5 A). To determine the contribution of PKR to the cytotoxicity caused by RNA
transfection, we pretreated cells with C16 to block PKR activation prior to RNA
transfection. As shown in Figure. 4.3.4 B, the cytotoxicity caused by both dsGFP and
B2RNA can be partially reversed by C16.
These data suggest that PKR activation contribute to the cytotoxicity associated with
antiviral responses in D−/−ESCs.

Figure 4.3.4. Contribution of PKR activation to the cytotoxicity caused by RNA
transfection in ESCs and D−/−ESCs. Cells were pretreated with C16 (1 μM) for 30 min
followed by transfection with dsGFP or B2 RNA. The cell viability was determined after 24 h
incubation using toluidine blue staining. The cell number in the control (Con, cells without any
treatment) was set as 100%. In all experiments, the values are as mean ± SD of a representative
experiments performed in biological triplicate that were performed at least twice. p < 0.01,**; p <
0.05*. Compared groups are indicated by a horizontal bar.
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4.4

Discussion
The difference in proliferation rate between ESCs and D-/-ESCs, the

abundance of cellular dsRNA structures in D-/-ESCs, possibility of these dsRNA to
activate PKR, and the role of PKR in cell division prompted us to study the
contribution of PKR activation in slowed proliferation rate of D-/-ESCs. Dicer
deficiency leads to constitutive PKR activation in D−/−ESCs. The constitutively
activated PKR in D−/−ESCs may have several biological implications. The PKR
pathway is functional in ESCs and is activated during mitosis by cellular dsRNA in a
highly regulated manner (Kim et al., 2014). We previously reported that polyICactivated PKR inhibits ESC proliferation, which can be partly reversed by PKR
knockdown with siRNA or by C16 PKR inhibitor treatment (D’Angelo et al., 2016).
The effect of polyIC was replicated with synthetic dsRNA and B2RNA in this study.
In addition to viral RNA, PKR can be activated by cellular RNA with certain features
of dsRNA, such as misprocessed RNA and transcripts of transposable elements (TEs)
(Nallagatla et al., 2011; Wang & Carmichael, 2004; White et al., 2015; Williams,
1999). Dicer is a key component in the pathway for siRNA and miRNA biogenesis. It
also plays a critical role in preventing the “sterile inflammatory response” by
silencing/processing endogenous RNA, in particular TE transcripts that are especially
abundant and active in early embryos (Hutchins & Pei, 2015). In human cells, Dicer
deficiency leads to accumulation of Alu, increased antiviral response, and accelerated
apoptosis (White et al., 2014). Furthermore, PKR is activated by ectopically expressed
Alu (Kim et al., 2014). B2RNA is the mouse counterpart of Alu in humans (Walters et
al., 2009). B2RNA, accumulated in D−/−ESCs, could be one of many cellular RNAs
accumulating from Dicer deletion that contribute to the constitutive activation of

66

PKR, leading to retarded cell cycle progression and reduced cell viability in
D−/−ESCs.
The rapid cell proliferation rate of ESCs is mainly driven by high levels of
cyclins A and E and the low levels of cell cycle inhibitors (Stead et al., 2002). ESCmiR-291a-3p, ESC-miR-294, and ESCmiR-295 directly target the mRNA of several
molecules, including p21, that inhibit cyclin/CDK activity (Mens & Ghanbari, 2018),
and this logically explains the high levels of p21 and p19 in D−/−ESCs and their slow
rate of proliferation. It appears that PKR inhibition by C16 in D−/−ESCs did not
directly affect the expression of p21, p19, or CDK2. However, this treatment
increased the expression level of CDC25A, a protein phosphatase that activates CDKs
and leads to G1/S cell cycle progression (Shen & Huang, 2012), which explains the
increased cell proliferation of D−/−ESCs in the presence of C16. It should be pointed
out that a comprehensive assessment of PKR activity on the functions of cell cycle
regulators is very difficult due to their large numbers and dynamic nature during the
cell cycle progression. However, it is fairly certain that global translation inhibition
caused by PKR activation via phosphorylation of eIF2α (Garcia et al., 2007) could be
a major mechanism of action of dsRNA and B2RNA.
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CHAPTER V – CONCLUSION

While the attenuated antiviral type I IFN signaling benefits ESCs by
preventing cytotoxicity associated during virus infections, it will be more plausible
only if an alternative antiviral mechanism is functional in these cells. It has been
shown that preexisted antiviral proteins provide intrinsic immunity to ESCs making
these cells non-permissive during virus infections (Wu et al., 2018). Moreover, virus
derived siRNA has also been detected during virus infections, although it is still
debatable whether antiviral RNAi prevents virus infectivity in ESCs (Maillard et al.,
2013). Using synthetic dsRNA as viral mimics, I found that although mammalian
Dicer can cleave these synthetic dsRNA, attenuated antiviral type I IFN signaling gets
activated upon loss of Dicer. Since D-/-ESCs has been used as loss of function model
to study antiviral RNAi, it would be difficult to clearly assess the contribution of
antiviral RNAi or activated type I IFN signaling in virus infectivity using this model
system. My study has hence determined D-/-ESCs not only as unsuitable model to
study antiviral RNAi, but also regulatory role of Dicer to suppress antiviral type I IFN
signaling in ESCs.
PKR is an intrinsically expressed antiviral protein in ESCs. Our previous
studies have shown that PKR is the only activated antiviral protein in mESCs during
virus infection and poly (IC) transfection(Wang et al., 2013) . Activation of PKR
phosphorylates translation inhibitor eIF2α which then inhibits translation of both viral
and cellular mRNA ultimately leading to apoptosis. I determined that PKR is
constitutively activated in D-/-ESCs which shows that Dicer also suppresses intrinsic
PKR activation to prevent cytotoxicity in ESCs. Moreover, I showed that retarded cell
proliferation of D-/-ESCs can be partially reversed by suppressing constitutively
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activated PKR leading to increased cell proliferation. Hence, Dicer also promotes
normal proliferation rate of ESCs by inhibiting PKR activation. In fibroblast-like
differentiated cells from ESCs, both virus infection and poly (IC) transfection
activates PKR causing increased cell death in these cells (D’Angelo et al., 2016).
However, in ESCs, although PKR is activated by virus infection and poly (IC), the
cytotoxicity is minimal and cell proliferation is only transiently inhibited (Wang et al.,
2013). PKR can hence be a suitable antiviral protein in ESCs. Moreover, its selfrenewal property is unaffected. To maintain its self-renewal property, ESCs use a
mechanism called translational switch in which the translation rate is lower than
transcription rate compared to differentiated cells. The substrate of PKR, eIF2α
regulates this mechanism by keeping general translation of cellular proteins at low
levels. However, peIF2α does not affect translation of pluripotency markers nanog
and c-Myc because they are translated by uORFs located at 5’UTR which is not
inhibited by peIF2α (Bulut-Karslioglu et al., 2018). Hence, PKR can be further
studied as a critical modulator of ‘translational switch’ in ESCs.
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